HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sufi M Thomas Selected Research

guggulu extract

2/2011Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma.
11/2009Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sufi M Thomas Research Topics

Disease

34Neoplasms (Cancer)
01/2022 - 07/2003
24Squamous Cell Carcinoma of Head and Neck
01/2021 - 07/2003
12Head and Neck Neoplasms (Head and Neck Cancer)
06/2014 - 09/2004
5Carcinogenesis
12/2019 - 09/2004
2Neoplasm Metastasis (Metastasis)
01/2022 - 09/2005
2Glioblastoma (Glioblastoma Multiforme)
01/2021 - 09/2006
1Disease Progression
01/2021
1Brain Neoplasms (Brain Tumor)
01/2021
1Glioma (Gliomas)
01/2021
1Wounds and Injuries (Trauma)
01/2020
1Renal Cell Carcinoma (Grawitz Tumor)
01/2020
1Adenocarcinoma
12/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2019
1Fibrosis (Cirrhosis)
11/2015
1Cicatrix (Scar)
11/2015
1Inflammation (Inflammations)
11/2015
1Radiation Fibrosis Syndrome (Radiation Fibrosis)
11/2015
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2013
1Carcinoma (Carcinomatosis)
01/2013
1Multiple Myeloma
12/2012
1Mouth Neoplasms (Oral Cancer)
07/2010
1Hypoxia (Hypoxemia)
11/2009

Drug/Important Bio-Agent (IBA)

22ErbB Receptors (EGF Receptor)IBA
06/2014 - 07/2003
8Cetuximab (Erbitux)FDA Link
02/2013 - 09/2006
7Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2009
7Erlotinib Hydrochloride (CP 358,774)FDA Link
06/2014 - 11/2009
4Phosphotransferases (Kinase)IBA
12/2019 - 09/2005
4Epidermal Growth Factor (EGF)IBA
01/2013 - 09/2004
4Biological ProductsIBA
11/2009 - 09/2006
4Gastrin-Releasing PeptideIBA
02/2009 - 09/2004
3DNA (Deoxyribonucleic Acid)IBA
01/2021 - 07/2003
3Tyrosine Kinase InhibitorsIBA
11/2012 - 06/2009
3LigandsIBA
03/2007 - 09/2004
2ChemokinesIBA
01/2022 - 09/2005
2Mitogen-Activated Protein KinasesIBA
01/2022 - 04/2007
2CollagenIBA
11/2015 - 02/2015
2Sulindac (Copal)FDA LinkGeneric
06/2014 - 11/2012
2Biomarkers (Surrogate Marker)IBA
06/2014 - 11/2012
2ONX 0912IBA
12/2012 - 10/2012
2carfilzomibIBA
12/2012 - 10/2012
2OligonucleotidesIBA
08/2012 - 05/2009
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
06/2012 - 05/2006
2guggulu extractIBA
02/2011 - 11/2009
2Cisplatin (Platino)FDA LinkGeneric
11/2009 - 09/2006
2saracatinibIBA
07/2008 - 07/2008
2src-Family KinasesIBA
07/2008 - 09/2004
2Bombesin Receptors (Bombesin Receptor)IBA
04/2007 - 09/2004
2Transforming Growth Factor alpha (TGF-alpha)IBA
10/2004 - 09/2004
1p38 Mitogen-Activated Protein KinasesIBA
01/2022
1Ion Channels (Ion Channel)IBA
01/2021
1A-Form DNA (A-DNA)IBA
10/2020
1Vasopressins (Vasopressin)IBA
01/2020
1Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
01/2020
1Complementary DNA (cDNA)IBA
01/2020
1TolvaptanFDA Link
01/2020
1Messenger RNA (mRNA)IBA
12/2019
1Calmodulin (Calcium-Dependent Activator Protein)IBA
12/2019
1Histone DemethylasesIBA
12/2019
1PhosphoproteinsIBA
03/2016
1NitrogenIBA
11/2015
1Oxygen (Dioxygen)IBA
11/2015
1CytokinesIBA
11/2015
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2015
1Celecoxib (Celebrex)FDA Link
03/2013
1Pharmaceutical PreparationsIBA
03/2013
1EnzymesIBA
03/2013
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2013
1Peptide Nucleic AcidsIBA
02/2013
1NucleotidesIBA
02/2013
1Guanidine (Guanidine Nitrate)FDA Link
02/2013
1glutarylphenylalanine-4-nitroanilideIBA
02/2013
1ThymidineIBA
01/2013
1Proteasome InhibitorsIBA
12/2012
1Bortezomib (Velcade)FDA Link
12/2012
1Mechanistic Target of Rapamycin Complex 2IBA
11/2012
1Blood Proteins (Serum Proteins)IBA
11/2012
1TOR Serine-Threonine KinasesIBA
11/2012
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
11/2012
1Mechanistic Target of Rapamycin Complex 1IBA
11/2012
1OSI 027IBA
11/2012
1Transcription Factors (Transcription Factor)IBA
08/2012
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
08/2012
1Phosphatidylinositols (Phosphatidylinositol)IBA
06/2012
170-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
08/2011
14-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA
02/2011
1Annexin A5IBA
05/2010
1honokiolIBA
05/2010
1pregna-4,17-diene-3,16-dione (guggulsterone)IBA
11/2009
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
06/2009
1CrizotinibIBA
06/2009

Therapy/Procedure

10Therapeutics
01/2021 - 07/2003
2Radiotherapy
01/2022 - 11/2015
2Chemoprevention
03/2013 - 02/2011
1Drug Therapy (Chemotherapy)
01/2022
1Precision Medicine
01/2021
1Injections
12/2019
1Molecular Targeted Therapy
01/2013
1Neoadjuvant Therapy
11/2012
1Oral Administration
10/2012
1Intravenous Injections
08/2012